PIM1 and B-cell chronic lymphocytic leukemia: CLL cells respond favorably to Pim kinase inhibitors– whereby K00135 and K00486 (two inhibitors which preferentially target Pim-1/− 2) and the pan-Pim inhibitor, A47, decreased CLL cell proliferation and apoptosis [124].